Grace E. Colón, Ph.D.
Dr. Grace E. Colón has a 30-year career spanning biopharma, genomics, diagnostics, digital health, synthetic and industrial biotechnology, venture capital, and entrepreneurship. She is co-founder of Inaya Therapeutics and was CEO of InCarda Therapeutics, raising $120M and advancing the lead program from pre-clinical stage to Phase 3. Previously she held leadership roles at Gilead Sciences, Intrexon, New Science Ventures, Affymetrix, and McKinsey. She serves on the board of Voyager Therapeutics (NASDAQ: VYGR), as board chair of Bloom Science and Emm, on the Board of the MIT Corporation, and as Vice Chair of the Emerging Companies Section and on the Board Executive Committee of the Biotechnology Innovation Organization (BIO).
Previously she served on the boards of CareDx (NASDAQ:CDNA) and on multiple early-stage biotech boards.
A native of Puerto Rico, she is passionate about advising and mentoring entrepreneurs as well as aspiring board directors, particularly women and underrepresented minorities. She is also an active advocate for women’s health, having experienced the long-term impact of severe endometriosis. She received her Ph.D. from MIT and a B.S.E. from the University of Pennsylvania, both in chemical engineering. In 2023 she was elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).
About the Sisterhood
The Biotech CEO Sisterhood is a vibrant community dedicated to championing the success of women leaders in the biopharma industry. Rooted in a culture of mutual support and authenticity, the Sisterhood aims to inspire and uplift women while driving meaningful conversations and impact across the industry. As part of our commitment to nurturing the current and future generations of biotech leaders, the Sisterhood hosts summits, local events, and educational sessions. These programs encourage dialogue about the challenges facing women in biotech, share best practices, and enhance leadership effectiveness. Since its inception in 2022, the Biotech CEO Sisterhood has grown to 300+ members. To follow our progress and learn more, please follow us on LinkedIn.
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.